Rice Hall James & Associates’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
93,612
+4,995
| +6% | +$73.9K | 0.07% | 187 |
|
|
2025
Q1 | $1.59M | Sell |
88,617
-4,041
| -4% | -$72.4K | 0.09% | 178 |
|
|
2024
Q4 | $1.61M | Sell |
92,658
-2,078
| -2% | -$36.2K | 0.09% | 190 |
|
|
2024
Q3 | $1.33M | Buy |
94,736
+18,562
| +24% | +$260K | 0.07% | 198 |
|
|
2024
Q2 | $626K | Buy |
76,174
+2,774
| +4% | +$22.8K | 0.04% | 220 |
|
|
2024
Q1 | $566K | Buy |
73,400
+3,140
| +4% | +$24.2K | 0.03% | 228 |
|
|
2023
Q4 | $632K | Sell |
70,260
-8,102
| -10% | -$72.8K | 0.04% | 236 |
|
|
2023
Q3 | $701K | Sell |
78,362
-1,481
| -2% | -$13.2K | 0.04% | 229 |
|
|
2023
Q2 | $1.23M | Buy |
79,843
+3,345
| +4% | +$51.4K | 0.07% | 205 |
|
|
2023
Q1 | $1.72M | Buy |
76,498
+290
| +0.4% | +$6.52K | 0.1% | 200 |
|
|
2022
Q4 | $1.6M | Sell |
76,208
-1,629
| -2% | -$34.3K | 0.09% | 210 |
|
|
2022
Q3 | $1.92M | Sell |
77,837
-24,154
| -24% | -$595K | 0.11% | 190 |
|
|
2022
Q2 | $2.47M | Buy |
101,991
+2,428
| +2% | +$58.8K | 0.12% | 172 |
|
|
2022
Q1 | $2.57M | Buy |
99,563
+3,387
| +4% | +$87.3K | 0.1% | 188 |
|
|
2021
Q4 | $2.99M | Sell |
96,176
-13,030
| -12% | -$404K | 0.11% | 176 |
|
|
2021
Q3 | $2.65M | Buy |
109,206
+2,379
| +2% | +$57.7K | 0.1% | 159 |
|
|
2021
Q2 | $1.56M | Sell |
106,827
-5,073
| -5% | -$74K | 0.06% | 233 |
|
|
2021
Q1 | $2.79M | Buy |
111,900
+36
| +0% | +$899 | 0.09% | 156 |
|
|
2020
Q4 | $3.05M | Buy |
+111,864
| New | +$3.05M | 0.11% | 141 |
|